This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Covidien LP. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations in Pain Management: The Contributions of Gary R. Strichartz
Introduction: Gary R. Strichartz, an esteemed inventor based in Natick, MA, has made significant strides in the field of pain management through his innovative work at Covidien LP. With one patent to his name, he has developed a novel approach to post-operative chronic pain relief that promises to enhance the quality of care for patients recovering from surgery.
Latest Patents: Strichartz's patent, titled "Drug Loaded Microspheres for Post-Operative Chronic Pain," presents a pioneering microsphere technology. This invention includes at least one biodegradable polymer and a local anesthetic, ensuring that approximately 75% of the anesthetic is released within 72 hours, with between 80% and 90% released by 120 hours. This sustained release mechanism effectively alleviates chronic pain for a minimum of 28 days, showcasing a significant advancement in pain management strategies.
Career Highlights: As a key contributor to Covidien LP, Strichartz has leveraged his expertise to develop innovative solutions that address critical healthcare challenges. His work focuses on enhancing patient outcomes, particularly in the realm of post-operative care. The impact of his invention is poised to transform therapeutic practices and improve recovery experiences for countless individuals.
Collaborations: Throughout his career, Strichartz has collaborated with talented professionals such as Rachit Ohri and Phillip Blaskovich. These partnerships have been instrumental in refining his inventions and ensuring that they meet the evolving needs of healthcare providers and patients alike.
Conclusion: Gary R. Strichartz's innovative contributions to pain management exemplify the importance of research and development in the medical field. His patented technology stands as a testament to his dedication to improving patient care and highlights the potential for continued advancements in chronic pain relief. As he continues his work at Covidien LP, Strichartz remains a vital figure in the pursuit of innovative healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile